N. Wada, “Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study”, J Clin Med Res, vol. 16, no. 10, pp. 503–508, Oct. 2024, doi: 10.14740/jocmr6031.